TGTX
Price
$37.67
Change
-$0.25 (-0.66%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
6.02B
25 days until earnings call
VSTM
Price
$4.74
Change
-$0.07 (-1.46%)
Updated
Jul 10 closing price
Capitalization
264.31M
Interact to see
Advertisement

TGTX vs VSTM

Header iconTGTX vs VSTM Comparison
Open Charts TGTX vs VSTMBanner chart's image
TG Therapeutics
Price$37.67
Change-$0.25 (-0.66%)
Volume$28.8K
Capitalization6.02B
Verastem
Price$4.74
Change-$0.07 (-1.46%)
Volume$1.59M
Capitalization264.31M
TGTX vs VSTM Comparison Chart in %
Loading...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TGTX vs. VSTM commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGTX is a Hold and VSTM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (TGTX: $37.92 vs. VSTM: $4.74)
Brand notoriety: TGTX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TGTX: 86% vs. VSTM: 64%
Market capitalization -- TGTX: $6.02B vs. VSTM: $264.31M
TGTX [@Biotechnology] is valued at $6.02B. VSTM’s [@Biotechnology] market capitalization is $264.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGTX’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • TGTX’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, TGTX is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGTX’s TA Score shows that 6 TA indicator(s) are bullish while VSTM’s TA Score has 5 bullish TA indicator(s).

  • TGTX’s TA Score: 6 bullish, 4 bearish.
  • VSTM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than VSTM.

Price Growth

TGTX (@Biotechnology) experienced а +4.49% price change this week, while VSTM (@Biotechnology) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

TGTX is expected to report earnings on Oct 30, 2025.

VSTM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($6.02B) has a higher market cap than VSTM($264M). TGTX YTD gains are higher at: 25.149 vs. VSTM (-8.317). TGTX has higher annual earnings (EBITDA): 70.5M vs. VSTM (-145.04M). TGTX has more cash in the bank: 132M vs. VSTM (118M). TGTX has less debt than VSTM: TGTX (8.98M) vs VSTM (76.8M). TGTX has higher revenues than VSTM: TGTX (386M) vs VSTM (10M).
TGTXVSTMTGTX / VSTM
Capitalization6.02B264M2,280%
EBITDA70.5M-145.04M-49%
Gain YTD25.149-8.317-302%
P/E Ratio150.68N/A-
Revenue386M10M3,860%
Total Cash132M118M112%
Total Debt8.98M76.8M12%
FUNDAMENTALS RATINGS
TGTX vs VSTM: Fundamental Ratings
TGTX
VSTM
OUTLOOK RATING
1..100
5652
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
4699
PRICE GROWTH RATING
1..100
4860
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VSTM's Valuation (81) in the Biotechnology industry is in the same range as TGTX (89). This means that VSTM’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as VSTM (100). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for VSTM (99). This means that TGTX’s stock grew somewhat faster than VSTM’s over the last 12 months.

TGTX's Price Growth Rating (48) in the Biotechnology industry is in the same range as VSTM (60). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for VSTM (100). This means that TGTX’s stock grew significantly faster than VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGTXVSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGAFF0.20N/A
+0.04%
Mega Uranium Ltd.
MCRUF2.95N/A
N/A
Morgan Advanced Materials PLC
FINMF52.75-0.95
-1.77%
Leonardo S.P.A.
DEFG21.85-3.40
-13.47%
Grayscale Decentralized Finance (DeFi) Fund LLC
CFEIY5.83-2.06
-26.13%
China Feihe Limited

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-0.66%
ARRY - TGTX
36%
Loosely correlated
-0.78%
CLLS - TGTX
36%
Loosely correlated
+1.54%
AXON - TGTX
36%
Loosely correlated
-9.04%
ROIV - TGTX
36%
Loosely correlated
+3.12%
CPRX - TGTX
36%
Loosely correlated
+1.04%
More